Home > Insider Trading > Filing (0001179110-18-012262)

Filing Details

Accession Number:: 0001179110-18-012262
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-10-17 19:26:54
Reporting Period:: 2018-10-15

Accepted Time:: 2018-10-17 19:26:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1646649	Jonathan Sheena	C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070	Chief Technology Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-10-15	25,491	$1.14	372,583	No	4	M	Direct
Common Stock	Acquisiton	2018-10-15	8,233	$2.66	380,816	No	4	M	Direct
Common Stock	Disposition	2018-10-15	33,724	$20.27	347,092	No	4	S	Direct
Common Stock	Disposition	2018-10-15	50,672	$20.29	296,420	No	4	S	Direct
Common Stock	Acquisiton	2018-10-16	16,276	$1.14	312,696	No	4	M	Direct
Common Stock	Disposition	2018-10-16	7,100	$20.62	305,596	No	4	S	Direct
Common Stock	Disposition	2018-10-16	9,176	$21.22	296,420	No	4	S	Direct
Common Stocj	Disposition	2018-10-16	11,791	$20.53	284,629	No	4	S	Direct
Common Stock	Disposition	2018-10-16	54,204	$21.20	230,425	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-10-15	25,491	$0.00	25,491	$1.14
Common Stock	Stock Option (right to buy)	Disposition	2018-10-15	8,233	$0.00	8,233	$2.66
Common Stock	Stock Option (right to buy)	Disposition	2018-10-16	16,276	$0.00	16,276	$1.14

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,276	2022-09-19	No	4	M	Direct
537,481	2024-02-25	No	4	M	Direct
0	2022-09-19	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2018.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.92 to $20.64 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.64 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vest fully and became exercisable on July 8, 2015.
The option shares vest fully and became exercisable on February 25, 2014.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.07 to $21.06 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.07 to $21.36 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.41 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Form 4 filed on November 25, 2016 ("Prior Filing") reflects an exercise of a stock option for 25,895 shares. The Prior Filing inadvertently included the exercise of 2,413 shares from a separate option granted to the Reporting Person on the same date understating the total amount beneficially owned following the reported transaction by 2,413 shares. The aggregate number of shares exercised on November 22, 2016 is correct as shown in Column 5. Prior to the transactions reported on this Form 4 the Reporting Person had a total of 41,767 shares remaining to exercise under the stock option.